Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)
Clinical trial NCT05351736 · UNKNOWN
Trial details
- NCT number
- NCT05351736
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2024-01-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.